NDC 70518-2100

Cymbalta

Duloxetine Hydrochloride

Cymbalta is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Duloxetine Hydrochloride.

Product ID70518-2100_8996c561-0f1c-604b-e053-2a95a90af5c2
NDC70518-2100
Product TypeHuman Prescription Drug
Proprietary NameCymbalta
Generic NameDuloxetine Hydrochloride
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2019-05-22
Marketing CategoryNDA / NDA
Application NumberNDA021427
Labeler NameREMEDYREPACK INC.
Substance NameDULOXETINE HYDROCHLORIDE
Active Ingredient Strength20 mg/1
Pharm ClassesNorepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-2100-0

30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (70518-2100-0)
Marketing Start Date2019-05-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-2100-0 [70518210000]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-22

Drug Details

Active Ingredients

IngredientStrength
DULOXETINE HYDROCHLORIDE20 mg/1

OpenFDA Data

SPL SET ID:71c5a674-f49f-423f-b1e2-af82bf947dfd
Manufacturer
UNII

Pharmacological Class

  • Norepinephrine Uptake Inhibitors [MoA]
  • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
  • Serotonin Uptake Inhibitors [MoA]

NDC Crossover Matching brand name "Cymbalta" or generic name "Duloxetine Hydrochloride"

NDCBrand NameGeneric Name
0002-3235CymbaltaDuloxetine hydrochloride
0002-3240CymbaltaDuloxetine hydrochloride
0002-3270CymbaltaDuloxetine hydrochloride
21695-145CymbaltaDuloxetine hydrochloride
21695-146CymbaltaDuloxetine hydrochloride
68151-4734CymbaltaCymbalta
68151-4679CymbaltaCymbalta
21695-657CymbaltaCymbalta
35356-843CymbaltaCymbalta
43353-303CymbaltaCymbalta
49999-618CymbaltaCymbalta
52959-892CymbaltaCymbalta
55289-028CymbaltaCymbalta
55289-036CymbaltaCymbalta
70518-2100CymbaltaCymbalta
70518-2099CymbaltaCymbalta
80425-0086CymbaltaCymbalta
80425-0119CymbaltaCymbalta
0904-7043DuloxetineDuloxetine Hydrochloride
0904-7044DuloxetineDuloxetine Hydrochloride
0904-7045DuloxetineDuloxetine Hydrochloride
0615-8034Duloxetine HydrochlorideDuloxetine Hydrochloride
0615-8035Duloxetine HydrochlorideDuloxetine Hydrochloride
0904-6452Duloxetine HydrochlorideDuloxetine Hydrochloride
0904-6453Duloxetine HydrochlorideDuloxetine Hydrochloride
0904-6454Duloxetine HydrochlorideDuloxetine Hydrochloride

Trademark Results [Cymbalta]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CYMBALTA
CYMBALTA
78859969 3194152 Live/Registered
Eli Lilly and Company
2006-04-12
CYMBALTA
CYMBALTA
76535580 not registered Dead/Abandoned
Eli Lilly and Company
2003-07-25
CYMBALTA
CYMBALTA
75867543 2802665 Live/Registered
Eli Lilly and Company
1999-12-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.